U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: August 30 - September 5, 2020
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: August 30 - September 5, 2020

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 09/01/2020
Location: Virtual
Subject: National Association of State Departments of Agriculture Annual Meeting: COVID-19 Response
FDA Participant/Group: N/A
Non FDA Participant/Group: Several commmissioners, secretaries, and directors of the State Departments of Agriculture participated

Event Date: 09/03/2020
Location: Teleconference
Subject: Arthritis Foundation Stakeholder Call: COVID-19 Update
FDA Participant/Group: DOUGLAS THROCKMORTON; KEAGAN LENIHAN; DAYLE CRISTINZIO; SCOTT WINIECKI;
Non FDA Participant/Group: Several leaders and members of the Arthritis Foundation

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 08/31/2020
Location: Virtual
Subject: Listening Session for FDA Staff with Greenleaf Research
FDA Participant/Group: JOSEPH FRANKLIN; DENNIS KEEFE; MICHELLE ADAMS; CASSANDRA TAYLOR; SHERENE SEPEHRI; APRIL ALEXANDROW; PATRICK CANNON; LOWELL SCHILLER; DOUGLAS THROCKMORTON; RACHEL OSTERMAN; YITONG LIU; PATRICK COURNOYER; JENIFER ROE; ALISON THOMPSON; SHARON MAYL; NAKISSA SADRIEH; TYNA DAO; MICHAEL LEVY; NATALIE GETZOFF; DAYLE CRISTINZIO;
Non FDA Participant/Group: Lisa De Azevedo, Todd Haryu (PreLabs); Andrew Podczerwinski, Jessica Humphreys (Greenleaf Research);

Event Date: 09/01/2020
Location: Virtual
Subject: Pharmaceutical Research and Manufacturers of America (PhRMA) - FDA Disccusion on COVID-19 Data
FDA Participant/Group: MARY SLACK; PETER MARKS; LAURA ROE; JACQUELINE CORRIGAN CURAY; JOSEPH FRANKLIN; MIMI NGUYEN; JULIA TIERNEY; ANDREW KISH; STEVEN ANDERSON; RAM IYER;
Non FDA Participant/Group: Anne Heatherington (Takeda); Ann Taylor (AstraZeneca); Eddie Reilly (Sanofi); James Mayne, Kelly Goldberg, Lucy Vereshchagina, Mary Kosinski, Richard Moscicki (PhRMA); Carl Garner (Eli Lilly); Mathai Mammen (Janssen); J.R. Meloro (Pfizer); Annetta Beauregard (Johnson & Johnson); Liz Roberts (UCB); John Tsai (Novartis); Tim Montague (GSK); Rob Lenz (Amgen);

Event Date: 09/02/2020
Location: Virtual
Subject: Healthcare Analytics Summit 2020 - Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, media, and other stakeholders

Event Date: 09/03/2020
Location: Virtual
Subject: Reagan-Udall Foundation: COVID-19 Evidence Accelerator Collaborative Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Patient groups, health care providers, industry, academia, and other stakeholders

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

No Significant Event

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: John Wagner, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 09/03/2020
Location: Teleconference
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: NADINE STEINBERG; DAVID EDWARDS; ANNE NORRIS; TRACEY FORFA; ANTONIA MONIQUE SENNETT; TIMOTHY SCHELL; WILLIAM FLYNN; JENNIFER ERICKSON; SIOBHAN DELANCEY; CHARLOTTE CONWAY;
Non FDA Participant/Group: American Feed Industry Association (AFIA)

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event

Back to Top